Anti Counterfeit Solutions for pharmaceutical Industry
Specialized Anti-counterfeiting solutions ensuring authenticity and trust, safeguarding brands and consumers alike.
Safeguarding Pharmaceuticals with Verify's Anti Counterfeiting Solutions
Verify is the vanguard in the battle against counterfeit pharmaceuticals, offering a comprehensive suite of cutting-edge solutions that redefine authenticity and safety standards within the industry. Our advanced technologies, including unique serialization codes, tamper-evident packaging, and real-time verification systems, empower pharmaceutical manufacturers, distributors, and healthcare providers to safeguard every medication, from production to patient consumption.
Through Verify’s platform, stakeholders gain unparalleled visibility and control over the entire supply chain, ensuring compliance with regulatory standards, mitigating risks of counterfeit products, and protecting patient welfare. Our robust authentication protocols not only verify the genuineness of pharmaceuticals but also detect and prevent unauthorized tampering or adulteration, preserving product integrity and efficacy.
Counterfeiters are winning because
No Advanced Anti Counterfeiting Solutions
Lack of Authentication Measures
Supply Chain Complexity
No User Rewards or Daily Use Hooks
Limited Consumer Awareness
Click here if you want to protect your brand from fakes
Verify Anti Counterfeit Solutions Helps
Proven Track
Record
Verify has a proven track record of success in combating counterfeit pharmaceuticals, with a portfolio of satisfied clients and successful case studies showcasing our effectiveness.
Advanced
Technology
We leverage advanced authentication technologies, such as blockchain, AI, and machine learning, to ensure robust security and accurate verification of pharmaceutical products.
Compliance and Regulatory Adherence
Verify’s solutions are designed to meet and exceed regulatory standards, ensuring full compliance with industry regulations and guidelines related to pharmaceutical authentication.
End-to-End Traceability
Our platform offers end-to-end traceability, enabling stakeholders to trace every pharmaceutical product’s journey throughout the supply chain, from manufacturing to distribution to the end consumer.
Real-Time Monitoring
Verify provides real-time monitoring capabilities, allowing stakeholders to detect and respond promptly to any suspicious activities or anomalies in the supply chain, minimizing the risk of counterfeit products reaching the market.
Customizable Solutions
We offer customizable solutions tailored to the specific needs and requirements of pharmaceutical companies, ensuring seamless integration with existing systems and processes.
Consumer Trust and Safety
By choosing Verify, pharmaceutical companies can enhance consumer trust and safety by guaranteeing the authenticity and quality of their products, ultimately protecting patient welfare and brand reputation.
Protect Your Pharmaceutical Brand with Verify's Anti-Counterfeiting Solutions
The pharmaceutical industry stands at a critical juncture, facing a formidable adversary that threatens patient safety, undermines trust, and exacts a substantial economic toll – counterfeit drugs. The staggering statistics paint a grim picture: a significant portion of global pharmaceuticals are counterfeit, leading to billions of dollars in losses and over 100,000 deaths annually. These alarming figures underscore the urgent need for decisive action and innovative solutions to combat this pervasive threat.
In this landscape fraught with challenges, Verify emerges as a beacon of hope and resilience. Through advanced technologies, regulatory adherence, and a steadfast commitment to patient welfare, Verify is poised to revolutionize pharmaceutical authentication and safeguard the integrity of medications across the supply chain. Join us on a journey to protect lives, restore trust, and ensure that every pill, vial, or capsule bears the hallmark of authenticity and quality.
10%
According to a report by the World Health Organization (WHO), approximately 10% of pharmaceuticals globally are counterfeit, with the percentage rising to over 30% in some regions.
$4 billion
The value of counterfeit pharmaceuticals seized globally has been estimated to exceed $4 billion annually, indicating the scale of the problem and the significant economic impact.
100k deaths
A study published in the International Journal of Health Policy and Management estimated that counterfeit drugs cause more than 100,000 deaths annually, highlighting the severe public health consequences.
20 million
Interpol, in collaboration with pharmaceutical industry associations, conducted a joint operation that resulted in the seizure of over 20 million counterfeit and illicit medicines,